BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3922393)

  • 1. A possible explanation for the absence of anti-anginal properties of transdermal nitroglycerin units: an echocardiographic study.
    Bennett ED; Davis AL
    Br J Clin Pharmacol; 1985 Apr; 19(4):435-40. PubMed ID: 3922393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antianginal effects of nitroglycerin during exercise-induced angina: hemodynamic and left ventricular function changes related to indexes of myocardial oxygen consumption.
    Choong CY; Roubin GS; Bautovich GJ; Harris PJ; Kelly DT
    Am J Cardiol; 1987 Nov; 60(15):10H-14H. PubMed ID: 3120560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemodynamic effects of angina pectoris, and of nitroglycerin in normal and anginal subjects.
    Hoeschen RJ; Bousvaros GA; Klassen GA; Fam WM; McGregor M
    Br Heart J; 1966 Mar; 28(2):221-30. PubMed ID: 5006472
    [No Abstract]   [Full Text] [Related]  

  • 4. A haemodynamic and pharmacokinetic study to assess a new transdermal nitroglycerin preparation in normal subjects.
    Bennett ED; Davis AL
    Eur J Clin Pharmacol; 1984; 26(3):293-6. PubMed ID: 6428912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bepridil-induced modifications of cardiac performance in the anesthetized dog: comparison with nitroglycerin and propranolol.
    Labrid C; Piris P; Lamar JC; Beaughard M
    Arch Int Pharmacodyn Ther; 1982 Feb; 255(2):293-308. PubMed ID: 6803695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in hemodynamic parameters, inotropic state, and myocardial oxygen consumption owing to intravenous application of nitroglycerin.
    Hempelmann G; Piepenbrock S; Seitz W; Karliczek G
    J Thorac Cardiovasc Surg; 1977 Jun; 73(6):836-47. PubMed ID: 404479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of serial radionuclide monitoring during graded nitroglycerin infusion for unstable angina pectoris for determining left ventricular function and individualized therapeutic dose.
    Breisblatt WM; Vita NA; Armuchastegui M; Cohen LS; Zaret BL
    Am J Cardiol; 1988 Apr; 61(10):685-90. PubMed ID: 3128097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of nitroglycerin on the major determinants of myocardial oxygen consumption. An angiographic and hemodynamic assessment.
    Greenberg H; Dwyer EM; Jameson AG; Pinkernell BH
    Am J Cardiol; 1975 Oct; 36(4):426-32. PubMed ID: 811105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the use of long acting nitrates beneficial in the patient with angina pectoris? (The positive side).
    Vyden JK; Takano TT; Rose HB; Ogawa T
    Cardiovasc Clin; 1977; 8(1):139-48. PubMed ID: 403004
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiovascular profile of 5 novel nitrate-esters: a comparative study with nitroglycerin in pigs with and without left ventricular dysfunction.
    van Woerkens LJ; van der Giessen WJ; Verdouw PD
    Br J Pharmacol; 1991 Sep; 104(1):7-14. PubMed ID: 1786521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anti-anginal action, by opposite mechanisms, of nitroglycerin and propranolol].
    Giani P; Folli G; Bruno L; Binaghi G; Rizzato GF; Bandera L
    Cuore Circ; 1969 Oct; 53(5):213-32. PubMed ID: 4984065
    [No Abstract]   [Full Text] [Related]  

  • 12. [Relations between ventricle function, myocardial oxygen consumption and coronary circulation following sublingual administration of nitroglycerin].
    Hahn N; Jehle J; Pölitz B; Schmiel FK; Spiller P
    Z Kardiol; 1983 Aug; 72(8):456-64. PubMed ID: 6414193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transdermal nitroglycerin (Transiderm-Nitro) in the treatment of unstable angina pectoris.
    Dahlstrøm CG; Rasmussen K; Bagger JP; Henningsen P; Haghfelt T
    Dan Med Bull; 1986 Oct; 33(5):265-7. PubMed ID: 3096643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiologic approach to the treatment of angina pectoris.
    Mason DT; Spann JF; Zelis R; Amsterdam EA
    N Engl J Med; 1969 Nov; 281(22):1225-8. PubMed ID: 4981526
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of sublingually and intravenously administered nitroglycerin on the cardiovascular system of the dog.
    Gillis RA; Melville KI
    Am J Cardiol; 1971 Jul; 28(1):38-42. PubMed ID: 4997142
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of nitroglycerin on left ventricular volumes and wall tension in patients with ischaemic heart disease.
    Lee SJ; Sung YK; Zaragoza AJ
    Br Heart J; 1970 Nov; 32(6):790-4. PubMed ID: 5006415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of intravenous administration of nitroglycerin on the indicators of central hemodynamics in patients with acute myocardial infarction].
    Afonskaia NI; Ostrogorskiĭ IuM; Karpov IuA; Ivanishvili LO; Iasinovskiĭ VD
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1983; 6(2):49-54. PubMed ID: 6416267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical therapy of angina pectoris.
    Parmley WW
    Angiology; 1977 Dec; 28(12):865-72. PubMed ID: 414639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of action of beta-blocking drugs in angina pectoris: a review.
    Robinson BF
    Postgrad Med J; 1976; 52 Suppl 4():43-5. PubMed ID: 9630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perhexilene maleate in treatment of angina pectoris.
    Lyon LJ; Nevins MA; Risch S; Henry S
    Lancet; 1971 Jun; 1(7712):1272-4. PubMed ID: 4104721
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.